Targeted funding how and why

Patiënt krijgt zorg in ziekenhuis

To maximize our impact, we have implemented changes in our funding strategy. In addition to our open calls (Exploration and Development), we have adopted a more targeted funding approach in thematic 'tracks'. 

This page explains how and why we implemented these tracks, and most importantly, how we involve(d) the oncoligcal field in this process.  


2019: Ambition 2030 & key areas 

In 2019, we defined a new strategic plan with our stakeholders: Ambition 2030.  This plan consists of five key areas that together encompass the entire patient journey (around which we organize our work):

  • Prevention through lifestyle and environmental factors
  • Early detection
  • Minimally invasive techniques
  • Cancer drugs
  • Psychosocial care 

Within these strategic key areas, researchers, policy makers, lobbyists and fundraisers work together to reach our goals.   


2022: Targeted funding 

Most research projects that were funded in our open calls, already align well with the key areas in our Ambition 2030. However, we also noticed that there were certain areas where our funding would not be sufficient to reach our goals. To improve funding for these themes, we generated targeted, long-term funding. 

In 2022, we conducted a survey, workshops and individual interviews with researchers to map the first areas.  


Funding in tracks

Thanks to the input we received from over 300 researchers, we have been able to formulate a several tracks: themes that we want to invest in more intensively and on a longer-term basis. Depending on the theme and on what is needed to achieve the goals of that theme, we will use instruments such as (structural) thematic calls, collaboratively designed funding, and direct network funding. 

All awarded KWF grants (both in open calls as well as through targeted funding) can be viewed here (in Dutch).
 

Basic research  

Basic research has always been (and will continue to be!) an integral part of our funding strategy, in open calls as well as in targeted funding of tracks and funding of Oncode Institute. Basic research forms the foundation of new and better treatments.

 

Work in progress 

This transition means a new way of working for KWF. This is a process that will take time. Some tracks have already been developed, others will start in the coming years, shifting the proportion of open calls relative to track funding. We are making these changes in collaboration with researchers in the field.  

You can stay up-to-date by signing up for our quarterly newsletter (Dutch), by checking our research page, or by asking our science liaisons.